These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11100804)

  • 1. Mechanisms of induction of tolerance to organ allografts.
    Hall BM
    Crit Rev Immunol; 2000; 20(4):267-324. PubMed ID: 11100804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From current immunosuppressive strategies to clinical tolerance of allografts.
    Golshayan D; Buhler L; Lechler RI; Pascual M
    Transpl Int; 2007 Jan; 20(1):12-24. PubMed ID: 17181648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixed chimerism achieved by a nonlethal conditioning regimen induces donor-specific tolerance to lung allografts.
    Li S; Salgar SK; Kurimoto Y; Yousem S; Pham SM
    J Surg Res; 2008 May; 146(2):289-97. PubMed ID: 18314139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adoptive transfusion of ex vivo donor alloantigen-stimulated CD4(+)CD25(+) regulatory T cells ameliorates rejection of DA-to-Lewis rat liver transplantation.
    Pu LY; Wang XH; Zhang F; Li XC; Yao AH; Yu Y; Lv L; Li GQ
    Surgery; 2007 Jul; 142(1):67-73. PubMed ID: 17630002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
    Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
    Talmadge JE
    Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of tolerance to alloantigen.
    Witzke O; Barbara JA; Wood KJ
    Rev Immunogenet; 1999; 1(3):374-86. PubMed ID: 11256428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exhaustive differentiation of alloreactive CD8+ T cells: critical for determination of graft acceptance or rejection.
    Steger U; Denecke C; Sawitzki B; Karim M; Jones ND; Wood KJ
    Transplantation; 2008 May; 85(9):1339-47. PubMed ID: 18475193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transplant tolerance associated with a Th1 response and not broken by IL-4, IL-5, and TGF-beta blockade or Th1 cytokine administration.
    Plain KM; Boyd R; Verma ND; Robinson CM; Tran GT; Hodgkinson SJ; Hall BM
    Transplantation; 2007 Mar; 83(6):764-73. PubMed ID: 17414711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organ transplant specificity of tolerance to skin grafts with heart or kidney grafts plus nondepleting anti-CD4 monoclonal antibody (RIB 5/2) and intravenous donor alloantigen administration.
    Otomo N; Margenthaler JA; Motoyama K; Arima T; Shimizu Y; Lehmann M; Flye MW
    J Surg Res; 2001 Jun; 98(1):59-65. PubMed ID: 11368539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New approaches to the prevention of organ allograft rejection and tolerance induction.
    Bagley J; Tian C; Iacomini J
    Transplantation; 2007 Jul; 84(1 Suppl):S38-41. PubMed ID: 17632412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerance induction in clinical transplantation.
    Fehr T; Sykes M
    Transpl Immunol; 2004; 13(2):117-30. PubMed ID: 15380542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
    Galili U
    Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absent mRNA accumulation of Th1 or Th2 cytokines in heart allografts with chimerism-based drug-induced tolerance.
    Tomita Y; Zhang QW; Matsuzaki G; Shimizu I; Iwai T; Okano S; Nomoto K; Yasui H
    Surg Today; 2005; 35(5):364-70. PubMed ID: 15864417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation.
    Kuo YR; Huang CW; Goto S; Wang CT; Hsu LW; Lin YC; Yang KD; Chen CL; Lee WP
    J Surg Res; 2009 May; 153(2):317-25. PubMed ID: 19101689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Present and future of immunosuppressive therapy].
    Eugui EM
    Medicina (B Aires); 2000; 60(1):67-80. PubMed ID: 10835702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory cells in transplantation.
    Wood KJ; Ushigome H; Karim M; Bushell A; Hori S; Sakaguchi S
    Novartis Found Symp; 2003; 252():177-88; discussion 188-93, 203-10. PubMed ID: 14609219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A short course of cyclosporine immunosuppression inhibits rejection but not tolerance of rat liver allografts.
    Huang WH; Yan Y; De Boer B; Bishop GA; House AK
    Transplantation; 2003 Feb; 75(3):368-74. PubMed ID: 12589161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific alloantigen self-control by regulatory T cells in organ transplantation: a review.
    Boschiero L; Nacchia F; Fior F; Cordiano C; Tridente G; Bellisola G
    Transplant Proc; 2007; 39(6):2013-7. PubMed ID: 17692679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.